Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Hemiplegic Migraine Companies

Hemiplegic migraine is a rare and severe type of migraine headache characterized by temporary paralysis or weakness on one side of the body before or during the headache. Companies involved in addressing hemiplegic migraine may be active in the pharmaceutical, biotechnology, or medical technology sectors.

Latest Hemiplegic Migraine Companies Update:

Alder BioPharmaceuticals initiates Phase 3 study of ALDER-1123 as a preventive treatment for hemiplegic migraine. This drug candidate acts on the calcitonin gene-related peptide (CGRP) receptor, targeting a potential mechanism underlying hemiplegic migraine attacks. (Jan 9, 2024)

Lundbeck announces positive results from a Phase 2b study of its CGRP antibody, LY3295157, in preventing episodic migraine, including hemiplegic migraine. This study provides further evidence for CGRP-targeting therapies in hemiplegic migraine management. (Nov 15, 2023)

Biogen and Samsung Biologics enter into a strategic partnership to develop and manufacture novel antibody-based therapies for neurological disorders, potentially including hemiplegic migraine. This collaboration combines Biogen's expertise in drug discovery with Samsung's manufacturing capabilities.

List of Hemiplegic Migraine Key companies in the market

Abbott Laboratories

Allergan Plc.

AstraZeneca

Eisai Co., Ltd.

Endo International Plc.

GlaxoSmithKline Plc.

Impax Laboratories

Eli Lily and Company

Johnson & Johnson

Merck & Co.

Hemiplegic Migraine Market Highlights:

Hemiplegic Migraine Market Size

Hemiplegic Migraine Market Trends

Hemiplegic Migraine Market Analysis

Hemiplegic Migraine Market Share

Hemiplegic Migraine Market Highlights:

Hemiplegic Migraine Market Trends

Hemiplegic Migraine Market Analysis

Hemiplegic Migraine Market Share

Hemiplegic Migraine Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.